Fig. 1From: Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case reportTimeline of cancer treatments from February 2015 to January 2018 with radiologic findings. Arrowheads showing left adrenal gland metastasis before initiation of Nivolumab (Dec 2015) and at 24 months with important partial response (Jan 2018)Back to article page